Document:

Exhibit 4.1

NEITHER THESE WARRANTS NOR THE COMMON STOCK ISSUABLE UPON EXERCISE OF THESE
WARRANTS HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE
"ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS AND MAY NOT BE SOLD, PLEDGED OR
TRANSFERRED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH
SECURITIES UNDER THE ACT OR UNLESS AN EXEMPTION FROM SUCH REGISTRATION IS
AVAILABLE.

1,600,000 Warrants                                                  June 8, 2005

                       PROTOCALL TECHNOLOGIES INCORPORATED

                                    WARRANTS

         Protocall Technologies Incorporated, a Nevada corporation ("PCLI"),
certifies that, for value received, Trilogy Capital Partners, Inc. ("Trilogy"),
or registered assigns (the "Holder"), is the owner of One Million Six Hundred
Thousand (1,600,000) Warrants of PCLI (the "Warrants"). Each Warrant entitles
the Holder to purchase from PCLI at any time prior to the Expiration Date (as
defined below) one share of the common stock of PCLI (the "Common Stock") for
$0.88 per share (the "Exercise Price"), on the terms and conditions hereinafter
provided. The Exercise Price and the number of shares of Common Stock
purchasable upon exercise of each Warrant are subject to adjustment as provided
in this Certificate.

1. VESTING; EXPIRATION DATE; EXERCISE

         1.1 Vesting. The Warrants shall vest and become exercisable as of the
date of this Certificate.

         1.2 Expiration Date. The Warrants shall expire on June 7, 2008 (the
"Expiration Date").

         1.3 Manner of Exercise. The Warrants are exercisable by delivery to
PCLI of the following (the "Exercise Documents"): (a) this Certificate (b) a
written notice of election to exercise the Warrants; and (c) payment of the
Exercise Price in cash, by check or by "net" exercise as contemplated by Section
1.4 of this Certificate. Within three business days following receipt of the
foregoing, PCLI shall execute and deliver to the Holder: (a) a certificate or
certificates representing the aggregate number of shares of Common Stock
purchased by the Holder, and (b) if less than all of the Warrants evidenced by
this Certificate are exercised, a new certificate evidencing the Warrants not so
exercised.

         1.4 Net Exercise. In lieu of the payment methods set forth in Section
1.3 above, the Holder may elect to exchange all or some of the Warrant for the
number of shares of Common Stock computed using the following formula:

                  X = Y (A-B)
                      -------
                         A

<PAGE>

                  Where X = the number of shares of Common Stock to be issued to
                  Holder.

                  Y = the number of shares of Common Stock purchasable under the
                  Warrants being exchanged (as adjusted to the date of such
                  calculation).

                  A = the Market Price on the date of receipt by PCLI of the
                  exercise documents.

                  B = the Exercise Price of the Warrants being exchanged (as
                  adjusted in accordance with the terms of Section 2 hereof).

                  The "Market Price" on any trading day shall be deemed to be
         the last reported sale price of the Common Stock on such day, or, in
         the case no such reported sales take place on such day, the last
         reported sale price on the preceding trading day on which there was a
         last reported sales price, as officially reported by the principal
         securities exchange in which the shares of Common Stock are listed or
         admitted to trading or by the Nasdaq Stock Market, or if the Common
         Stock is not listed or admitted to trading on any national securities
         exchange or the Nasdaq Stock Market, the last sale price, or if there
         is no last sale price, the closing bid price, as furnished by the
         National Association of Securities Dealers, Inc. (such as through the
         OTC Bulletin Board) or a similar organization or if Nasdaq is no longer
         reporting such information. If the Market Price cannot be determined
         pursuant to the sentence above, the Market Price shall be determined in
         good faith (using customary valuation methods) by the Board of
         Directors of PCLI based on the information best available to it,
         including recent arms-length sales of Common Stock to unaffiliated
         persons.

         1.5 Warrant Exercise Limitation. Notwithstanding any other provision of
this Agreement, if as of the date of exercise PCLI has a class of securities
registered under Section 12 of the Securities Exchange Act of 1934, as amended,
Holder may not exercise Warrants under this Section 1 to the extent that
immediately following such exercise Holder would beneficially own 5% or more of
the outstanding Common Stock of PCLI. For this purpose, a representation of the
Holder that following such exercise it would not beneficially own 5% or more of
the outstanding Common Stock of PCLI shall be conclusive and binding upon PCLI.

2. ADJUSTMENTS OF EXERCISE PRICE AND NUMBER AND KIND OF CONVERSION SHARES

         2.1 In the event that PCLI shall at any time hereafter (a) pay a
dividend in Common Stock or securities convertible into Common Stock; (b)
subdivide or split its outstanding Common Stock; (c) combine its outstanding
Common Stock into a smaller number of shares; then the number of shares to be
issued immediately after the occurrence of any such event shall be adjusted so
that the Holder thereafter may receive the number of shares of Common Stock it
would have owned immediately following such action if it had exercised the
Warrants immediately prior to such action and the Exercise Price shall be
adjusted to reflect such proportionate increases or decreases in the number of
shares.

         2.2 In case of any reclassification of the outstanding shares of Common
Stock (other than a change covered by Section 2.1 hereof or a change which
solely affects the par value of such shares) or in the case of any merger or
consolidation or merger in which PCLI is not the continuing corporation and
which results in any reclassification or capital reorganization of the
outstanding shares), the Holder shall

                                      -2-
<PAGE>

have the right thereafter (until the Expiration Date) to receive upon the
exercise hereof, for the same aggregate Exercise Price payable hereunder
immediately prior to such event, the kind and amount of shares of stock or other
securities or property receivable upon such reclassification, capital
reorganization, merger or consolidation, by a Holder of the number of shares of
Common Stock obtainable upon the exercise of the Warrants immediately prior to
such event; and if any reclassification also results in a change in shares
covered by Section 2.1, then such adjustment shall be made pursuant to both this
Section 2.2 and Section 2.1 (without duplication). The provisions of this
Section 2.2 shall similarly apply to successive reclassifications, capital
reorganizations and mergers or consolidations, sales or other transfers.

3. RESERVATION OF SHARES. PCLI shall at all times reserve and keep available out
of its authorized but unissued shares of Common Stock, such number of shares of
Common Stock as shall from time to time be issuable upon exercise of the
Warrants. If at any time the number of authorized but unissued shares of Common
Stock shall not be sufficient to permit the exercise of the Warrants, PCLI shall
promptly seek such corporate action as may necessary to increase its authorized
but unissued shares of Common Stock to such number of shares as shall be
sufficient for such purpose.

4. CERTIFICATE AS TO ADJUSTMENTS. In each case of any adjustment in the Exercise
Price, or number or type of shares issuable upon exercise of these Warrants, the
Chief Financial Officer of PCLI shall compute such adjustment in accordance with
the terms of these Warrants and prepare a certificate setting forth such
adjustment and showing in detail the facts upon which such adjustment is based,
including a statement of the adjusted Exercise Price. PCLI shall promptly send
(by facsimile and by either first class mail, postage prepaid or overnight
delivery) a copy of each such certificate to the Holder.

5. LOSS OR MUTILATION. Upon receipt of evidence reasonably satisfactory to PCLI
of the ownership of and the loss, theft, destruction or mutilation of this
Certificate, and of indemnity reasonably satisfactory to it, and (in the case of
mutilation) upon surrender and cancellation of these Warrants, PCLI will execute
and deliver in lieu thereof a new Certificate of like tenor as the lost, stolen,
destroyed or mutilated Certificate.

6. REPRESENTATIONS AND WARRANTIES OF PCLI. PCLI hereby represents and warrants
to Holder that:

         6.1 Due Authorization. All corporate action on the part of PCLI, its
officers, directors and shareholders necessary for (a) the authorization,
execution and delivery of, and the performance of all obligations of PCLI under,
these Warrants, and (b) the authorization, issuance, reservation for issuance
and delivery of all of the Common Stock issuable upon exercise of these
Warrants, has been duly taken. These Warrants constitute a valid and binding
obligation of PCLI enforceable in accordance with their terms, subject, as to
enforcement of remedies, to applicable bankruptcy, insolvency, moratorium,
reorganization and similar laws affecting creditors' rights generally and to
general equitable principles.

         6.2 Organization. PCLI is a corporation duly organized, validly
existing and in good standing under the laws of the State referenced in the
first paragraph of this Certificate and has all requisite corporate power to
own, lease and operate its property and to carry on its business as now being
conducted and as currently proposed to be conducted.

         6.3 Valid Issuance of Stock. Any shares of Common Stock issued upon
exercise of these Warrants will be duly and validly issued, fully paid and
non-assessable.

                                      -3-
<PAGE>

         6.4 Governmental Consents. All consents, approvals, orders,
authorizations or registrations, qualifications, declarations or filings with
any federal or state governmental authority on the part of PCLI required in
connection with the consummation of the transactions contemplated herein have
been obtained.

7. REPRESENTATIONS AND WARRANTIES OF TRILOGY. Trilogy hereby represents and
warrants to PCLI that:

         7.1 Trilogy is acquiring the Warrants for its own account, for
investment purposes only.

         7.2 Trilogy understands that an investment in the Warrants involves a
high degree of risk, and Trilogy has the financial ability to bear the economic
risk of this investment in the Warrants, including a complete loss of such
investment. Trilogy has adequate means for providing for its current financial
needs and has no need for liquidity with respect to this investment.

         7.3 Trilogy has such knowledge and experience in financial and business
matters that it is capable of evaluating the merits and risks of an investment
in the Warrants and in protecting its own interest in connection with this
transaction.

         7.4 Trilogy understands that the Warrants have not been registered
under the Securities Act of 1933, as amended (the "Securities Act") or under any
state securities laws. Trilogy is familiar with the provisions of the Securities
Act and Rule 144 thereunder and understands that the restrictions on transfer on
the Warrants may result in Trilogy being required to hold the Warrants for an
indefinite period of time.

         7.5 Trilogy agrees not to sell, transfer, assign, gift, create a
security interest in, or otherwise dispose of, with or without consideration
(collectively, "Transfer") any of the Warrants except pursuant to an effective
registration statement under the Securities Act or an exemption from
registration. As a further condition to any such Transfer, except in the event
that such Transfer is made pursuant to an effective registration statement under
the Securities Act, if in the reasonable opinion of counsel to PCLI any Transfer
of the Warrants by the contemplated transferee thereof would not be exempt from
the registration and prospectus delivery requirements of the Securities Act,
PCLI may require the contemplated transferee to furnish PCLI with an investment
letter setting forth such information and agreements as may be reasonably
requested by PCLI to ensure compliance by such transferee with the Securities
Act.

8. NOTICES OF RECORD DATE

                  In the event:

         8.1 PCLI shall take a record of the holders of its Common Stock (or
other stock or securities at the time receivable upon the exercise of these
Warrants), for the purpose of entitling them to receive any dividend or other
distribution, or any right to subscribe for or purchase any shares of stock of
any class or any other securities or to receive any other right; or

         8.2 of any consolidation or merger of PCLI with or into another
corporation, any capital reorganization of PCLI, any reclassification of the
capital stock of PCLI, or any conveyance of all or

                                      -4-
<PAGE>

substantially all of the assets of PCLI to another corporation in which holders
of PCLI's stock are to receive stock, securities or property of another
corporation; or

         8.3 of any voluntary dissolution, liquidation or winding-up of PCLI; or

         8.4 of any redemption or conversion of all outstanding Common Stock;

then, and in each such case, PCLI will mail or cause to be mailed to the Holder
a notice specifying, as the case may be, (a) the date on which a record is to be
taken for the purpose of such dividend, distribution or right, or (b) the date
on which such reorganization, reclassification, consolidation, merger,
conveyance, dissolution, liquidation, winding-up, redemption or conversion is to
take place, and the time, if any is to be fixed, as of which the holders of
record of Common Stock (or such stock or securities as at the time are
receivable upon the exercise of these Warrants), shall be entitled to exchange
their shares of Common Stock (or such other stock or securities), for securities
or other property deliverable upon such reorganization, reclassification,
consolidation, merger, conveyance, dissolution, liquidation or winding-up. PCLI
shall use all reasonable efforts to ensure such notice shall be delivered at
least 15 days prior to the date therein specified.

9. REGISTRATION RIGHTS.

         9.1 Definitions. For purposes of this Section 9, the following terms
shall have the meanings set forth below:

               9.1.1 A "Blackout Event" means any of the following: (a) the
possession by PCLI of material information that is not ripe for disclosure in a
registration statement or prospectus, as determined reasonably and in good faith
by the Chief Executive Officer or the Board of Directors of PCLI or that
disclosure of such information in the Registration Statement or the prospectus
constituting a part thereof would be materially detrimental to the business and
affairs of PCLI; or (b) any material engagement or activity by PCLI which would,
in the reasonable and good faith determination of the Chief Executive Officer or
the Board of Directors of PCLI, be materially adversely affected by disclosure
in a registration statement or prospectus at such time.

               9.1.2 "Exchange Act" shall mean the Securities Exchange Act of
1934, as amended.

               9.1.3 "Included Shares" shall mean any Registrable Shares
included in a Registration.

               9.1.4 "Registrable Shares" shall mean the shares of Common Stock
(or such stock or securities as at the time are receivable upon the exercise of
these Warrants) issuable upon exercise of the Warrants and any other warrants
and or other securities issued to Trilogy in connection with performing investor
relations services for PCLI, and shares or securities issued as a result of
stock split, stock dividend or reclassification of such shares.

               9.1.5 "Registration" shall mean a registration of securities
under the Securities Act pursuant to Section 9.2 or 9.3 of this Agreement.

               9.1.6 "Registration Period" with respect to any Registration
Statement the period commencing the effective date of the Registration Statement
and ending upon withdrawal or termination of the Registration Statement.

                                      -5-
<PAGE>

               9.1.7 "Registration Statement" shall mean the registration
statement, as amended from time to time, filed with the SEC in connection with a
Registration.

               9.1.8 "SEC" shall mean the Securities and Exchange Commission.

         9.2 Demand Registration. No later than August 15, 2005, PCLI shall
prepare and file with the SEC a Registration Statement for the purpose of
registering the sale of the Registrable Shares under the Securities Act, and
shall use its commercially reasonable efforts to cause the Registration
Statement to become effective within 60 days of the date of filing. Once
effective, PCLI shall prepare and file with the SEC such amendments and
supplements to the Registration Statement and the prospectus forming a part
thereof as may be necessary to keep the Registration Statement effective until
the earliest date on which (a) all the Included Shares have been disposed of
pursuant to the Registration Statement, or (b) all of the Included Shares then
held by Holder may be sold under the provisions of Rule 144 without limitation
as to volume, whether pursuant to Rule 144(k) or otherwise.

         9.3 Piggyback Registration. Unless the Registrable Shares are then
included in a Registration Statement or can be sold under the provisions of Rule
144 without limitation as to volume, whether pursuant to Rule 144(k) or
otherwise, if PCLI shall determine to register any Common Stock under the
Securities Act for sale in connection with a public offering of Common Stock
(other than pursuant to an employee benefit plan or a merger, acquisition or
similar transaction), PCLI will give written notice thereof to Holder and will
include in such Registration Statement any of the Registrable Shares which
Holder may request be included ("Included Shares") by a writing delivered to
PCLI within 15 days after the notice given by PCLI to Holder; provided, however,
that if the offering is to be firmly underwritten, and the representative of the
underwriters of the offering refuse in writing to include in the offering all of
the shares of Common Stock requested by PCLI and others, the shares to be
included shall be allocated first to PCLI and any shareholder who initiated such
Registration and then among the others based on the respective number of shares
of Common Stock held by such persons. If PCLI decides not to, and does not, file
a Registration Statement with respect to such Registration, or after filing
determines to withdraw the same before the effective date thereof, PCLI will
promptly so inform Holder, and PCLI will not be obligated to complete the
registration of the Included Shares included therein.

         9.4 Certain Covenants. In connection with any Registration:

               9.4.1 PCLI shall take all lawful action such that the
Registration Statement, any amendment thereto and the prospectus forming a part
thereof does not contain an untrue statement of a material fact or omit to state
a material fact required to be stated therein or necessary to make the
statements therein, in light of the circumstances under which they are made, not
misleading. Upon becoming aware of the occurrence of any event or the discovery
of any facts during the Registration Period that make any statement of a
material fact made in the Registration Statement or the related prospectus
untrue in any material respect or which material fact is omitted from the
Registration Statement or related prospectus that requires the making of any
changes in the Registration Statement or related prospectus so that it will not
contain any untrue statement of a material fact or omit to state a material fact
necessary to make the statements therein, in light of the circumstances under
which they are made, not misleading (taking into account any prior amendments or
supplements), PCLI shall promptly notify Holder, and, subject to the provisions
of Section 9.5, as soon as reasonably practicable prepare (but, subject to
Section 9.5, in no event more than five business days in the case of a
supplement or seven business days in the case of a post-effective amendment) and
file with the SEC a

                                      -6-
<PAGE>

supplement or post-effective amendment to the Registration Statement or the
related prospectus or file any other required document so that, as thereafter
delivered to a purchaser of Shares from Holder, such prospectus will not contain
any untrue statement of a material fact or omit to state a material fact
necessary to make the statements therein, in light of the circumstances under
which they were made, not misleading.

               9.4.2 At least three business days prior to the filing with the
SEC of the Registration Statement (or any amendment thereto) or the prospectus
forming a part thereof (or any supplement thereto), PCLI shall provide draft
copies thereof to Holder and shall consider incorporating into such documents
such comments as Holder (and its counsel) may propose to be incorporated
therein. Notwithstanding the foregoing, no prospectus supplement, the form of
which has previously been provided to Holder, need be delivered in draft form to
Holder.

               9.4.3 PCLI shall promptly notify Holder upon the occurrence of
any of the following events in respect of the Registration Statement or the
prospectus forming a part thereof: (a) the receipt of any request for additional
information from the SEC or any other federal or state governmental authority,
the response to which would require any amendments or supplements to the
Registration Statement or related prospectus; (b) the issuance by the SEC or any
other federal or state governmental authority of any stop order suspending the
effectiveness of the Registration Statement or the initiation of any proceedings
for that purpose; or (c) the receipt of any notification with respect to the
suspension of the qualification or exemption from qualification of any of the
Shares for sale in any jurisdiction or the initiation or threatening of any
proceeding for such purpose.

               9.4.4 PCLI shall furnish to Holder with respect to the Included
Shares registered under the Registration Statement (and to each underwriter, if
any, of such Shares) such number of copies of prospectuses and such other
documents as Holder may reasonably request, in order to facilitate the public
sale or other disposition of all or any of the Included Shares by Holder
pursuant to the Registration Statement.

               9.4.5 In connection with any registration pursuant to Section
9.2, PCLI shall file or cause to be filed such documents as are required to be
filed by PCLI for normal Blue Sky clearance in states specified in writing by
Holder; provided, however, that PCLI shall not be required to qualify to do
business or consent to service of process in any jurisdiction in which it is not
now so qualified or has not so consented.

               9.4.6 PCLI shall bear and pay all expenses incurred by it and
Holder (other than underwriting discounts, brokerage fees and commissions and
fees and expenses of more than one law firm) in connection with the registration
of the Shares pursuant to the Registration Statement.

               9.4.7 PCLI shall require each legal opinion and accountant's
"cold comfort" letter in connection with the Registration, if any, to be
rendered to Holder as well as PCLI and/or its Board of Directors.

               9.4.8 As a condition to including Registrable Shares in a
Registration Statement, Holder must provide to PCLI such information regarding
itself, the Registrable Shares held by it and the intended method of
distribution of such Shares as shall be required to effect the registration of
the Registrable Shares and, if the offering is being underwritten, Holder must
provide such powers of

                                      -7-
<PAGE>

attorney, indemnities and other documents as may be reasonably requested by the
managing underwriter.

               9.4.9 Following the effectiveness of the Registration Statement,
upon receipt from PCLI of a notice that the Registration Statement contains an
untrue statement of material fact or omits to state any material fact required
to be stated therein or necessary to make the statements therein not misleading
in light of the circumstances under which they were made, Holder will
immediately discontinue disposition of Included Shares pursuant to the
Registration Statement until PCLI notifies Holder that it may resume sales of
Included Shares and, if necessary, provides to Holder copies of the supplemental
or amended prospectus.

         9.5 Blackout Event. PCLI shall not be obligated to file a
post-effective amendment or supplement to the Registration Statement or the
prospectus constituting a part thereof during the continuance of a Blackout
Event; provided, however, that no Blackout Event may be deemed to exist for more
than 60 days. Without the express written consent of Holder, if required to
permit the continued sale of Shares by Holder, a post-effective amendment or
supplement to Registration Statement or the prospectus constituting a part
thereof must be filed no later than the 61st day following commencement of a
Blackout Event.

         9.6 Rule 144. With a view to making available to Holder the benefits of
Rule 144, PCLI agrees, until such time as Holder can sell all remaining
Registrable Shares under the provisions Rule 144(k), to:

               9.6.1.1 comply with the provisions of paragraph (c)(1) of Rule
144; and

               9.6.1.2 file with the SEC in a timely manner all reports and
other documents required to be filed by PCLI pursuant to Section 13 or 15(d)
under the Exchange Act; and, if at any time it is not required to file such
reports but in the past had been required to or did file such reports, it will,
upon the request of a Purchaser, make available other information as required
by, and so long as necessary to permit sales of its Shares pursuant to, Rule
144.

         9.7 PCLI Indemnification. PCLI agrees to indemnify and hold harmless
Holder, and its officers, directors and agents (including broker or underwriter
selling Included Shares for Holder), and each person, if any, who controls
Holder within the meaning of Section 15 of the Securities Act or Section 20 of
the Exchange Act from and against any and all losses, claims, damages and
liabilities caused by (a) any violation or alleged violation by PCLI of the
Securities Act, Exchange Act, any state securities laws or any rule or
regulation promulgated under the Securities Act, Exchange Act or any state
securities laws, (b) any untrue statement or alleged untrue statement of a
material fact contained in any registration statement or prospectus relating to
the Included Shares (as amended or supplemented if PCLI shall have furnished any
amendments or supplements thereto) or any preliminary prospectus, or (c) caused
by any omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein not misleading in
light of the circumstances under which they were made, except insofar as such
losses, claims, damages or liabilities are caused by any such untrue statement
or omission or alleged untrue statement or omission based upon information
furnished in writing to PCLI by Holder or on Holder's behalf expressly for use
therein.

         9.8 Holder Indemnification. Holder agrees to indemnify and hold
harmless PCLI, its officers, directors and agents and each person, if any, who
controls PCLI within the meaning of either Section 15 of the Securities Act or
Section 20 of the Exchange Act to the same extent as the foregoing indemnity

                                      -8-
<PAGE>

from PCLI to Holder, but only with respect to information furnished in writing
by Holder or on Holder's behalf expressly for use in any registration statement
or prospectus relating to the Registrable Shares, or any amendment or supplement
thereto, or any preliminary prospectus.

         9.9 Indemnification Procedures. In case any proceeding (including any
governmental investigation) shall be instituted involving any person in respect
of which indemnity may be sought pursuant to this Section 9, such person (an
"Indemnified Party") shall promptly notify the person against whom such
indemnity may be sought (the "Indemnifying Party") in writing and the
Indemnifying Party shall assume the defense thereof, including the employment of
counsel reasonably satisfactory to such Indemnified Party, and shall assume the
payment of all fees and expenses; provided that the failure of any Indemnified
Party so to notify the Indemnifying Party shall not relieve the Indemnifying
Party of its obligations hereunder except to the extent (and only to the extent
that) that the Indemnifying Party is materially prejudiced by such failure to
notify. In any such proceeding, any Indemnified Party shall have the right to
retain its own counsel, but the fees and expenses of such counsel shall be at
the expense of such Indemnified Party unless (a) the Indemnifying Party and the
Indemnified Party shall have mutually agreed to the retention of such counsel or
(b) in the reasonable judgment of such Indemnified Party representation of both
parties by the same counsel would be inappropriate due to actual or potential
differing interests between them. It is understood that the Indemnifying Party
shall not, in connection with any proceeding or related proceedings in the same
jurisdiction, be liable for the reasonable fees and expenses of more than one
separate firm of attorneys (in addition to any local counsel) at any time for
all such Indemnified Parties (including in the case of Holder, all of its
officers, directors and controlling persons) and that all such fees and expenses
shall be reimbursed as they are incurred. In the case of any such separate firm
for the Indemnified Parties, the Indemnified Parties shall designate such firm
in writing to the Indemnifying Party. The Indemnifying Party shall not be liable
for any settlement of any proceeding effected without its written consent (which
consent shall not be unreasonably withheld or delayed), but if settled with such
consent, or if there be a final judgment for the plaintiff, the Indemnifying
Party shall indemnify and hold harmless such Indemnified Parties from and
against any loss or liability (to the extent stated above) by reason of such
settlement or judgment. No Indemnifying Party shall, without the prior written
consent of the Indemnified Party, effect any settlement of any pending or
threatened proceeding in respect of which any Indemnified Party is or could have
been a party and indemnity could have been sought hereunder by such Indemnified
Party, unless such settlement includes an unconditional release of such
Indemnified Party from all liability arising out of such proceeding.

         9.10 Contribution. To the extent any indemnification by an Indemnifying
Party is prohibited or limited by law, the Indemnifying Party agrees to make the
maximum contribution with respect to any amounts for which, he, she or it would
otherwise be liable under this Section 9 to the fullest extent permitted by law;
provided, however, that (a) no contribution shall be made under circumstances
where a party would not have been liable for indemnification under this Section
9 and (b) no seller of Registrable Securities guilty of fraudulent
misrepresentation (within the meaning used in the Securities Act) shall be
entitled to contribution from any party who was not guilty of such fraudulent
misrepresentation.

10. NONTRANSFERABILITY. Trilogy may not sell or transfer any Warrants to any
person other than a director, officer, employee, manager or affiliate of Trilogy
(or a person controlled by one or more directors, officers, employees, managers
or affiliates of Trilogy) or to a person or entity that assists Trilogy in
providing services to PCLI pursuant to the Letter of Engagement dated June 8,
2005 as the same may be amended from time to time, without the consent of PCLI.

                                      -9-
<PAGE>

11. SEVERABILITY. If any term, provision, covenant or restriction of these
Warrants is held by a court of competent jurisdiction to be invalid, void or
unenforceable, the remainder of the terms, provisions, covenants and
restrictions of these Warrants shall remain in full force and effect and shall
in no way be affected, impaired or invalidated.

12. NOTICES. All notices, requests, consents and other communications required
hereunder shall be in writing and shall be effective when delivered or, if
delivered by registered or certified mail, postage prepaid, return receipt
requested, shall be effective on the third day following deposit in United
States mail: to the Holder, at Trilogy Capital Partners, Inc., 11726 San Vicente
Boulevard, Suite 235, Los Angeles, CA 90049; and if addressed to PCLI, at
Protocall Technologies Incorporated, 47 Mall Drive, Commack, NY 11725, or such
other address as Holder or PCLI may designate in writing.

13. NO RIGHTS AS SHAREHOLDER. The Holder shall have no rights as a shareholder
of PCLI with respect to the shares issuable upon exercise of the Warrants until
the receipt by PCLI of all of the Exercise Documents.

                                    Protocall Technologies Incorporated

                                    By:
                                       -----------------------------------------
                                       Mark Benedikt, Chief Executive Officer

                                      -10-
<PAGE>

                                   EXHIBIT "A"
                               NOTICE OF EXERCISE
                (To be signed only upon exercise of the Warrants)

To:      Protocall Technologies Incorporated

         The undersigned hereby elects to purchase shares of Common Stock (the
"Warrant Shares") of Protocall Technologies Incorporated ("PCLI"), pursuant to
the terms of the enclosed warrant certificate (the "Certificate"). The
undersigned tenders herewith payment of the exercise price pursuant to the terms
of the Certificate.

         The undersigned hereby represents and warrants to, and agrees with,
PCLI as follows:

         1. Holder is acquiring the Warrant Shares for its own account, for
investment purposes only.

         2. Holder understands that an investment in the Warrant Shares involves
a high degree of risk, and Holder has the financial ability to bear the economic
risk of this investment in the Warrant Shares, including a complete loss of such
investment. Holder has adequate means for providing for its current financial
needs and has no need for liquidity with respect to this investment.

         3. Holder has such knowledge and experience in financial and business
matters that it is capable of evaluating the merits and risks of an investment
in the Warrant Shares and in protecting its own interest in connection with this
transaction.

         4. Holder understands that the Warrant Shares have not been registered
under the Securities Act or under any state securities laws. Holder is familiar
with the provisions of the Securities Act and Rule 144 thereunder and
understands that the restrictions on transfer on the Warrant Shares may result
in Holder being required to hold the Warrant Shares for an indefinite period of
time.

         5. Holder agrees not to sell, transfer, assign, gift, create a security
interest in, or otherwise dispose of, with or without consideration
(collectively, "Transfer") any of the Warrant Shares except pursuant to an
effective registration statement under the Securities Act or an exemption from
registration. As a further condition to any such Transfer, except in the event
that such Transfer is made pursuant to an effective registration statement under
the Securities Act, if in the reasonable opinion of counsel to PCLI any Transfer
of the Warrant Shares by the contemplated transferee thereof would not be exempt
from the registration and prospectus delivery requirements of the Securities
Act, PCLI may require the contemplated transferee to furnish PCLI with an
investment letter setting forth such information and agreements as may be
reasonably requested by PCLI to ensure compliance by such transferee with the
Securities Act.

<PAGE>

         Each certificate evidencing the Warrant Shares will bear the following
legend:

"THE SECURITIES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933 (THE "ACT") OR ANY APPLICABLE STATE SECURITIES LAWS
AND MAY NOT BE EXERCISED, SOLD, PLEDGED OR TRANSFERRED IN THE ABSENCE OF AN
EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE ACT OR UNLESS AN
EXEMPTION FROM SUCH REGISTRATION IS AVAILABLE.

         6. Immediately following this exercise of Warrants, if as of the date
of exercise PCLI has a class of securities registered under Section 12 of the
Securities Exchange Act of 1934, as amended, the undersigned will not
beneficially own five percent (5%) or more of the then outstanding Common Stock
of PCLI (based on the number of shares outstanding set forth in the most recent
periodic report filed by PCLI with the Securities and Exchange Commission and
any additional shares which have been issued since that date of which Holder is
aware have been issued).

Number of Warrants Exercised:  ______________

Net Exercise  ____  Yes  ___ No

Dated:  ____________________

                                                --------------------------------Exhibit 10-a

                SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT

      THIS SEVENTH AMENDMENT TO LOAN AND SECURITY AGREEMENT (the "Amendment") is
made as of this 30th day of June, 2005, by and between RONSON CONSUMER  PRODUCTS
CORPORATION,  a New Jersey  corporation  (the  "Borrower")  and BANK OF AMERICA,
N.A., successor-by-merger to Fleet National Bank (the "Lender").

      WHEREAS,  the  Borrower  and the Lender are parties to a certain  Loan and
Security  Agreement  dated  January  6,  1995  as  amended  from  time  to  time
(collectively, the "Loan Agreement"), relating to financing by the Lender to the
Borrower (all capitalized terms used, but not specifically defined herein, shall
have the meaning provided for such terms in the Loan Agreement); and

      WHEREAS,  the  Borrower  has  requested  and the Lender has agreed to make
certain revisions to the terms and conditions of the Loan Agreement,  as amended
by the Amendment; and

      WHEREAS, to induce the Lender to amend certain terms and conditions of the
Loan Agreement, the Borrower has offered to execute and deliver the Amendment.

      NOW,  THEREFORE,  in  consideration of the foregoing and of other good and
valuable  consideration,  the  receipt  and  sufficiency  of  which  are  hereby
acknowledged, the Lender and the Borrower agree as follows:

      1.  As of the  date of  this  Amendment  Subsection  6.33(e)  of the  Loan
Agreement is hereby deleted in its entirety with no material to be placed in its
stead.

      2.  Notwithstanding  anything  contained  in  the  Loan  Documents  to the
contrary,  it is agreed and understood  that all Obligations are due and payable
in full on September 30, 2005.

      3. The Borrower shall pay on demand all legal fees, recording expenses and
other  reasonable  and  necessary  disbursements  of the Lender and its  counsel
incident to the preparation, execution and delivery of this Amendment.

      4. The Borrower  acknowledges  that its obligations to the Lender pursuant
to the Loan Agreement,  as amended herein,  are due and owing by the Borrower to
the Lender without any defenses, set-offs,  recoupments, claims or counterclaims
of any kind as of the date hereof.  To the extent that any  defenses,  set-offs,
recoupments,  claims  or  counterclaims  may  exist as of the date  hereof,  the
Borrower waives and releases the Lender from the same.

      5. The  Borrower  hereby  agrees  with,  reaffirms  and  acknowledges  the
representations and warranties contained in the Loan Agreement. Furthermore, the
Borrower  represents that the  representations  and warranties  contained in the
Loan Agreement continue to be true and in full force and effect. This agreement,
reaffirmation and  acknowledgment is given to the Lender by the Borrower without
defenses,  claims or  counterclaims  of any kind.  To the  extent  that any such

<PAGE>

defenses,  claims or  counterclaims  against the Lender may exist,  the Borrower
waives and releases the Lender from the same.

      6. The Borrower  ratifies and reaffirms all terms,  covenants,  conditions
and  agreements  contained  in  the  Loan  Agreement.   All  terms,   covenants,
representations  and warranties made to Lender by Borrower in the Loan Agreement
are to be true,  accurate  and complete for the duration of the term of the Loan
Agreement.

      7. All other terms and conditions of the Loan  Agreement,  and any and all
Exhibits annexed thereto and all other writings submitted by the Borrower to the
Lender pursuant thereto, shall remain unchanged and in full force and effect.

      8. This Amendment  shall not constitute a waiver or modification of any of
the Lender's rights and remedies or of any of the terms, conditions, warranties,
representations,  or  covenants  contained  in the  Loan  Agreement,  except  as
specifically  set forth above,  and the Lender hereby reserves all of its rights
and remedies pursuant to the Loan Agreement and applicable law.

      9. The failure of the Borrower to satisfy any of the terms and  conditions
of this Amendment shall constitute an Event of Default under the Loan Agreement,
and the Lender  shall be  entitled to all of its rights and  remedies  under the
Loan Agreement and applicable law.

      10. This Amendment may be executed in  counterparts,  each of which,  when
taken together, shall be deemed to be one and the same instrument.

      Executed on the date first written above.

WITNESS:                              RONSON CONSUMER PRODUCTS
                                      CORPORATION

/s/ Daryl K. Holcomb                  By: /s/ Louis V. Aronson, II
-----------------------------             ----------------------------------
Daryl K. Holcomb                          Louis V. Aronson, II
Vice President                            President and Chief Executive Officer

                                      BANK OF AMERICA, N.A.
                                      successor-by-merger to Fleet National Bank

                                      By: /s/ Kathleen Auth
                                          ----------------------------------
                                          Kathleen Auth
                                          Vice President

                                      -2-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]